menu search

Satsuma pharmaceuticals provides sts101 development program and corporate update

Further analysis of results from recently-completed SUMMIT Phase 3 efficacy trial of sts101 for the acu...

December 20, 2022, 2:21 pm


Search within

Pages Search Results: